Neurokinin 3 Receptor Antagonist [EPC]

Neurokinin 3 Receptor Antagonist [EPC] was reported 2301 times

Drugs of the Neurokinin 3 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DIAMINE OXIDASE DEFICIENCY 1 0.2500
1 PRODUCT ADMINISTERED IN INAPPROPRIATE SETTING 1 0.2000
2 GASTRIC ELECTRICAL STIMULATION 1 0.1429
3 BLEPHARORRHAPHY 1 0.0625
4 ORTHOSTATIC HEART RATE RESPONSE INCREASED 1 0.0556
5 DENTAL IMPLANT REMOVAL 1 0.0526
6 NON-FUNCTIONAL KIDNEY 1 0.0455
7 BLOOD ZINC INCREASED 1 0.0333
8 SEX HORMONE BINDING GLOBULIN DECREASED 1 0.0333
9 PRIMARY HYPOPARATHYROIDISM 1 0.0312
10 PRODUCT DESICCANT ISSUE 1 0.0294
11 STERNOTOMY 1 0.0244
12 PORCELAIN GALLBLADDER 1 0.0189
13 SEPTIC RASH 1 0.0167
14 CATHETER SITE DISCOMFORT 1 0.0125
15 ALPHA 1 GLOBULIN INCREASED 1 0.0125
16 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
17 PHYLLODES TUMOUR 1 0.0123
18 TONGUE ROUGH 1 0.0118
19 ORAL MUCOSAL ROUGHENING 1 0.0118
20 ANAL RASH 1 0.0104
21 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
22 GINGIVAL GRAFT 1 0.0088
23 EPSTEIN-BARR VIRUS ANTIGEN POSITIVE 1 0.0086
24 LICHEN PLANOPILARIS 1 0.0085
25 MENOPAUSAL DISORDER 1 0.0078
26 OVARIAN VEIN THROMBOSIS 1 0.0066
27 FEMALE ORGASMIC DISORDER 2 0.0060
28 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 1 0.0057
29 BILE ACIDS INCREASED 1 0.0056
30 OSTEOMA 1 0.0056
31 GENITOURINARY SYMPTOM 1 0.0055
32 EXAGGERATED STARTLE RESPONSE 1 0.0055
33 ANTIDEPRESSANT DISCONTINUATION SYNDROME 1 0.0048
34 LIVER FUNCTION TEST INCREASED 98 0.0046
35 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
36 MENOPAUSAL SYMPTOMS 10 0.0043
37 CARCINOID TUMOUR PULMONARY 1 0.0041
38 DRUG-DISEASE INTERACTION 3 0.0041
39 SKULL FRACTURED BASE 1 0.0040
40 TONGUE GEOGRAPHIC 1 0.0040
41 OSCILLOPSIA 1 0.0039
42 RED BLOOD CELL SEDIMENTATION RATE DECREASED 1 0.0038
43 DUMPING SYNDROME 1 0.0038
44 ONYCHOPHAGIA 1 0.0036
45 GENITAL BLISTER 1 0.0036
46 VOCAL CORD POLYP 1 0.0035
47 OESTRADIOL INCREASED 1 0.0033
48 BUTTOCK INJURY 1 0.0033
49 ALANINE AMINOTRANSFERASE INCREASED 200 0.0033
50 HEPATIC ENZYME INCREASED 217 0.0032
51 CONDUCTIVE DEAFNESS 1 0.0031
52 PNEUMOCEPHALUS 1 0.0030
53 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
54 ASPARTATE AMINOTRANSFERASE INCREASED 153 0.0029
55 FACIAL DISCOMFORT 2 0.0028
56 BIPOLAR II DISORDER 1 0.0028
57 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
58 LID SULCUS DEEPENED 1 0.0027
59 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
60 HOUSEBOUND 1 0.0025
61 LOSS OF THERAPEUTIC RESPONSE 8 0.0025
62 GENITAL ABSCESS 1 0.0025
63 PERSISTENT DEPRESSIVE DISORDER 1 0.0025
64 ALVEOLAR OSTEITIS 1 0.0024
65 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
66 MOUTH BREATHING 1 0.0023
67 HEPATIC ENZYME DECREASED 1 0.0022
68 PERINATAL DEPRESSION 1 0.0022
69 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
70 SKIN INDENTATION 1 0.0021
71 OPIATES POSITIVE 1 0.0021
72 LACTATION DISORDER 1 0.0021
73 HERPES ZOSTER OTICUS 1 0.0020
74 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
75 GAMMA-GLUTAMYLTRANSFERASE INCREASED 43 0.0019
76 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
77 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
78 TOBACCO ABUSE 1 0.0019
79 HEPATIC PAIN 8 0.0019
80 SCIATIC NERVE NEUROPATHY 1 0.0019
81 HEPATIC ENZYME ABNORMAL 9 0.0018
82 FAECES PALE 4 0.0018
83 MUSCLE RUPTURE 7 0.0018
84 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 1 0.0016
85 THYROXINE FREE INCREASED 1 0.0016
86 BLADDER IRRITATION 1 0.0016
87 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
88 BLOOD ALKALINE PHOSPHATASE INCREASED 38 0.0015
89 TRIPLE NEGATIVE BREAST CANCER 1 0.0015
90 TRANSAMINASES INCREASED 33 0.0015
91 CARBON DIOXIDE INCREASED 2 0.0015
92 HOT FLUSH 107 0.0014
93 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
94 TRANSIENT GLOBAL AMNESIA 1 0.0014
95 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
96 INDIFFERENCE 1 0.0013
97 CORNEAL TRANSPLANT 1 0.0013
98 BRAIN FOG 20 0.0013
99 GALLBLADDER POLYP 1 0.0013
100 STOMACH MASS 1 0.0013
101 INHIBITORY DRUG INTERACTION 2 0.0013
102 THYROID HORMONES DECREASED 1 0.0013
103 NIGHT BLINDNESS 2 0.0012
104 FOOD AVERSION 2 0.0012
105 ENZYME LEVEL INCREASED 1 0.0012
106 ENTERITIS INFECTIOUS 2 0.0012
107 SYMPTOM RECURRENCE 7 0.0012
108 CRANIOFACIAL FRACTURE 1 0.0012
109 ALLERGIC SINUSITIS 1 0.0012
110 CORONARY ARTERY DISSECTION 1 0.0012
111 ENDOCRINE OPHTHALMOPATHY 1 0.0012
112 NIGHT SWEATS 37 0.0011
113 VERTIGO POSITIONAL 2 0.0011
114 UPPER AIRWAY OBSTRUCTION 1 0.0011
115 JAW OPERATION 1 0.0011
116 BLOOD MAGNESIUM INCREASED 1 0.0011
117 NUCHAL RIGIDITY 1 0.0011
118 SENSITIVE SKIN 8 0.0011
119 BONE GRAFT 1 0.0011
120 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
121 PRINZMETAL ANGINA 1 0.0010
122 BLOOD BILIRUBIN INCREASED 27 0.0010
123 BREAST DISCOMFORT 1 0.0010
124 BREAST NEOPLASM 1 0.0010
125 OCULAR ICTERUS 4 0.0009
126 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
127 PERIARTHRITIS 2 0.0009
128 CORTISOL DECREASED 1 0.0009
129 ADMINISTRATION SITE PAIN 1 0.0009
130 PALMAR ERYTHEMA 1 0.0009
131 LUMBAR RADICULOPATHY 1 0.0009
132 NEPHROCALCINOSIS 1 0.0008
133 CHRONIC RESPIRATORY FAILURE 1 0.0008
134 INFUSION SITE WARMTH 1 0.0008
135 POST-ACUTE COVID-19 SYNDROME 1 0.0008
136 INTERVERTEBRAL DISC OPERATION 1 0.0008
137 BLOOD UREA DECREASED 1 0.0008
138 VAGINAL ODOUR 1 0.0008
139 HYPERAESTHESIA TEETH 1 0.0008
140 BRONCHIAL SECRETION RETENTION 1 0.0008
141 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
142 BLOOD BILIRUBIN ABNORMAL 1 0.0008
143 INFUSION SITE IRRITATION 1 0.0008
144 HERPES OPHTHALMIC 1 0.0008
145 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
146 HYPOVITAMINOSIS 1 0.0008
147 YAWNING 2 0.0007
148 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
149 HEAD TITUBATION 1 0.0007
150 TENSION HEADACHE 3 0.0007
151 PANCREATIC ENZYMES INCREASED 1 0.0007
152 GENERALISED ANXIETY DISORDER 1 0.0007
153 AXILLARY PAIN 1 0.0007
154 CHOLANGIOCARCINOMA 1 0.0007
155 ATYPICAL PNEUMONIA 2 0.0007
156 GASTROINTESTINAL WALL THICKENING 1 0.0007
157 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
158 ORAL MUCOSAL ERUPTION 1 0.0007
159 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
160 POLYCYSTIC OVARIES 1 0.0006
161 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
162 PHARYNGEAL PARAESTHESIA 1 0.0006
163 CHROMATURIA 14 0.0006
164 VULVOVAGINAL DRYNESS 2 0.0006
165 SKULL FRACTURE 1 0.0006
166 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
167 LIVER FUNCTION TEST ABNORMAL 17 0.0006
168 BLOOD CHLORIDE INCREASED 1 0.0006
169 SPONDYLOLISTHESIS 1 0.0006
170 HYPERTRANSAMINASAEMIA 4 0.0006
171 EMOTIONAL POVERTY 1 0.0006
172 INFUSION SITE DISCHARGE 1 0.0006
173 DRUG SCREEN NEGATIVE 1 0.0006
174 TERMINAL INSOMNIA 1 0.0006
175 HEAD DISCOMFORT 10 0.0006
176 GLOSSITIS 2 0.0006
177 UTERINE POLYP 1 0.0006
178 ESSENTIAL HYPERTENSION 1 0.0005
179 BODY TEMPERATURE ABNORMAL 1 0.0005
180 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
181 OESOPHAGEAL SPASM 1 0.0005
182 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
183 DENTAL CARE 1 0.0005
184 CATHETER PLACEMENT 1 0.0005
185 HYPERACUSIS 2 0.0005
186 IMPATIENCE 1 0.0005
187 SACROILIITIS 1 0.0005
188 HEPATIC MASS 1 0.0005
189 MOTION SICKNESS 1 0.0005
190 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
191 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
192 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
193 SKIN ODOUR ABNORMAL 2 0.0005
194 ENURESIS 2 0.0005
195 VENOUS THROMBOSIS LIMB 1 0.0005
196 HYPERTHYROIDISM 7 0.0005
197 BLEPHAROSPASM 3 0.0005
198 EYE CONTUSION 1 0.0005
199 SLEEP DEFICIT 1 0.0005
200 UTERINE HAEMORRHAGE 2 0.0005
201 HEPATIC LESION 2 0.0005
202 SOMNAMBULISM 3 0.0005
203 LIVER DISORDER 20 0.0005
204 TEMPERATURE REGULATION DISORDER 1 0.0004
205 LIVER INJURY 11 0.0004
206 GASTRIC POLYPS 1 0.0004
207 SUSPECTED OFF LABEL USE 2 0.0004
208 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
209 HAEMATOCRIT INCREASED 1 0.0004
210 ORAL PRURITUS 1 0.0004
211 RENAL FUNCTION TEST ABNORMAL 2 0.0004
212 BILIRUBIN CONJUGATED INCREASED 1 0.0004
213 ORAL SURGERY 1 0.0004
214 SKIN HAEMORRHAGE 6 0.0004
215 NIGHTMARE 14 0.0004
216 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
217 INITIAL INSOMNIA 4 0.0004
218 ABNORMAL UTERINE BLEEDING 1 0.0004
219 MEAN CELL VOLUME INCREASED 1 0.0004
220 MENOPAUSE 1 0.0004
221 HEPATITIS TOXIC 1 0.0004
222 RADICULOPATHY 1 0.0004
223 SERUM FERRITIN INCREASED 2 0.0004
224 NYSTAGMUS 2 0.0004
225 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
226 ANIMAL BITE 1 0.0004
227 MIDDLE INSOMNIA 7 0.0004
228 STEATORRHOEA 1 0.0004
229 ABDOMINAL MASS 1 0.0004
230 BREAST SWELLING 1 0.0004
231 ABDOMINAL RIGIDITY 1 0.0004
232 ANORGASMIA 1 0.0004
233 MIGRAINE WITH AURA 1 0.0004
234 BLOOD PHOSPHORUS INCREASED 1 0.0004
235 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
236 RED BLOOD CELL COUNT INCREASED 1 0.0004
237 HEPATOTOXICITY 8 0.0004
238 ELECTRIC SHOCK SENSATION 1 0.0004
239 INSOMNIA 94 0.0004
240 BILIARY COLIC 1 0.0003
241 BRADYKINESIA 2 0.0003
242 DISEASE RECURRENCE 16 0.0003
243 EMBOLISM VENOUS 1 0.0003
244 DYSCHEZIA 1 0.0003
245 FLANK PAIN 3 0.0003
246 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
247 INFUSION SITE PRURITUS 1 0.0003
248 POLYMYALGIA RHEUMATICA 1 0.0003
249 BILE DUCT STONE 1 0.0003
250 ABDOMINAL PAIN 72 0.0003
251 CARDIAC FLUTTER 2 0.0003
252 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
253 PHARYNGEAL SWELLING 3 0.0003
254 BRADYPHRENIA 2 0.0003
255 DEAFNESS NEUROSENSORY 1 0.0003
256 LISTLESS 1 0.0003
257 OTITIS MEDIA 1 0.0003
258 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
259 MENINGITIS 2 0.0003
260 BREAST MASS 2 0.0003
261 JAUNDICE 8 0.0003
262 BRONCHIECTASIS 2 0.0003
263 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
264 NEOPLASM RECURRENCE 1 0.0003
265 HEPATIC FUNCTION ABNORMAL 11 0.0003
266 EYE MOVEMENT DISORDER 2 0.0003
267 WOUND COMPLICATION 1 0.0003
268 BLOOD CREATININE ABNORMAL 1 0.0003
269 EXTRASYSTOLES 2 0.0003
270 CAROTID ARTERY STENOSIS 1 0.0003
271 DEPRESSIVE SYMPTOM 1 0.0003
272 SEASONAL ALLERGY 4 0.0003
273 SKIN WEEPING 1 0.0003
274 VERTIGO 17 0.0003
275 PARAESTHESIA ORAL 4 0.0003
276 UTERINE LEIOMYOMA 2 0.0003
277 SEBORRHOEA 1 0.0003
278 AMYLASE INCREASED 1 0.0003
279 PSYCHIATRIC SYMPTOM 2 0.0003
280 HYPERTENSIVE CRISIS 3 0.0003
281 HEPATIC STEATOSIS 5 0.0003
282 BREAST TENDERNESS 2 0.0003
283 SNORING 1 0.0003
284 IMPAIRED DRIVING ABILITY 3 0.0003
285 MIGRAINE 25 0.0003
286 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
287 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
288 NAIL DISCOLOURATION 1 0.0003
289 OBSTRUCTION 1 0.0003
290 TRIGEMINAL NEURALGIA 1 0.0002
291 NOCTURIA 3 0.0002
292 FIBROMYALGIA 6 0.0002
293 HOMICIDAL IDEATION 1 0.0002
294 SPINAL FUSION SURGERY 1 0.0002
295 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
296 BLOOD POTASSIUM INCREASED 4 0.0002
297 RECURRENT CANCER 1 0.0002
298 ABNORMAL FAECES 2 0.0002
299 CHOLELITHIASIS 8 0.0002
300 BACK PAIN 56 0.0002
301 ONYCHOMADESIS 1 0.0002
302 SLEEP TERROR 1 0.0002
303 MUSCLE FATIGUE 1 0.0002
304 TONGUE DISCOMFORT 1 0.0002
305 ABSCESS LIMB 1 0.0002
306 INTERVERTEBRAL DISC DISORDER 1 0.0002
307 ABNORMAL SENSATION IN EYE 1 0.0002
308 HORDEOLUM 1 0.0002
309 FAECES DISCOLOURED 5 0.0002
310 SKIN SWELLING 2 0.0002
311 DIVERTICULUM INTESTINAL 1 0.0002
312 ABDOMINAL PAIN UPPER 47 0.0002
313 SLEEP DISORDER 16 0.0002
314 GINGIVAL SWELLING 1 0.0002
315 BLOOD CREATINE INCREASED 1 0.0002
316 OROPHARYNGEAL DISCOMFORT 2 0.0002
317 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
318 HAEMOGLOBIN INCREASED 1 0.0002
319 DISEASE COMPLICATION 1 0.0002
320 IMMUNE THROMBOCYTOPENIA 1 0.0002
321 DYSPAREUNIA 1 0.0002
322 INCREASED TENDENCY TO BRUISE 2 0.0002
323 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
324 ABNORMAL DREAMS 6 0.0002
325 EYE OPERATION 1 0.0002
326 ORAL DISCOMFORT 3 0.0002
327 THERAPY CESSATION 11 0.0002
328 DIARRHOEA HAEMORRHAGIC 2 0.0002
329 YELLOW SKIN 1 0.0002
330 PALPITATIONS 25 0.0002
331 DRUG INEFFECTIVE 281 0.0002
332 SKIN TIGHTNESS 1 0.0002
333 ARRHYTHMIA 10 0.0002
334 SARCOIDOSIS 1 0.0002
335 FEELING JITTERY 4 0.0002
336 HEADACHE 130 0.0002
337 DIZZINESS POSTURAL 2 0.0002
338 AUTOIMMUNE DISORDER 2 0.0002
339 INCORRECT DOSAGE ADMINISTERED 1 0.0002
340 HEPATOMEGALY 2 0.0002
341 THERAPY CHANGE 2 0.0002
342 MUCOUS STOOLS 1 0.0002
343 INFLAMMATORY MARKER INCREASED 1 0.0002
344 INABILITY TO AFFORD MEDICATION 2 0.0002
345 ANEURYSM 1 0.0002
346 BLOOD CREATININE INCREASED 13 0.0002
347 HEPATIC FAILURE 6 0.0002
348 INSURANCE ISSUE 3 0.0002
349 PETIT MAL EPILEPSY 1 0.0002
350 PRODUCT COLOUR ISSUE 1 0.0002
351 TRISMUS 1 0.0002
352 SWOLLEN TONGUE 6 0.0002
353 DRUG-INDUCED LIVER INJURY 6 0.0002
354 FOOD CRAVING 1 0.0002
355 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
356 SCIATICA 3 0.0002
357 BREAST PAIN 2 0.0002
358 FOOD POISONING 1 0.0002
359 IRRITABLE BOWEL SYNDROME 4 0.0002
360 PRODUCT SIZE ISSUE 1 0.0002
361 INJECTION SITE DISCHARGE 1 0.0002
362 POOR QUALITY SLEEP 4 0.0002
363 DECREASED ACTIVITY 2 0.0002
364 CHEILITIS 1 0.0002
365 PRODUCT PRESCRIBING ISSUE 4 0.0002
366 JAW DISORDER 1 0.0002
367 NONSPECIFIC REACTION 1 0.0002
368 ASTHENOPIA 1 0.0002
369 PHOTOSENSITIVITY REACTION 3 0.0002
370 GASTRIC ULCER HAEMORRHAGE 1 0.0002
371 ON AND OFF PHENOMENON 1 0.0002
372 FEELING COLD 5 0.0002
373 HEART RATE ABNORMAL 1 0.0002
374 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
375 OCULAR DISCOMFORT 2 0.0002
376 CANDIDA INFECTION 3 0.0002
377 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
378 PERIORBITAL SWELLING 1 0.0002
379 DRUG INTERACTION 28 0.0002
380 RHEUMATOID FACTOR POSITIVE 1 0.0002
381 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
382 DYSSTASIA 5 0.0002
383 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
384 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
385 CATARACT OPERATION 1 0.0002
386 GALLBLADDER DISORDER 3 0.0002
387 THYROID CANCER 2 0.0002
388 APHASIA 5 0.0002
389 PRESYNCOPE 4 0.0002
390 VULVOVAGINAL BURNING SENSATION 1 0.0002
391 INFUSION SITE EXTRAVASATION 1 0.0002
392 DYSARTHRIA 6 0.0002
393 INFUSION SITE SWELLING 1 0.0002
394 THERAPEUTIC RESPONSE CHANGED 1 0.0002
395 INCREASED APPETITE 3 0.0002
396 BLOOD PRESSURE INCREASED 24 0.0002
397 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
398 ERUCTATION 3 0.0002
399 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
400 HEPATITIS ACUTE 1 0.0002
401 PANCREATITIS 8 0.0002
402 EAR INFECTION 4 0.0002
403 IRRITABILITY 9 0.0001
404 POST-TRAUMATIC STRESS DISORDER 1 0.0001
405 INTENTIONAL PRODUCT MISUSE 13 0.0001
406 METASTASES TO LYMPH NODES 1 0.0001
407 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 30 0.0001
408 WRONG PRODUCT ADMINISTERED 1 0.0001
409 FEEDING DISORDER 3 0.0001
410 TASTE DISORDER 3 0.0001
411 ULCER HAEMORRHAGE 1 0.0001
412 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
413 PRODUCT LABEL ISSUE 1 0.0001
414 BLOOD TESTOSTERONE DECREASED 1 0.0001
415 PERIPHERAL COLDNESS 2 0.0001
416 CONDITION AGGRAVATED 44 0.0001
417 HAIR GROWTH ABNORMAL 1 0.0001
418 DIVERTICULITIS 4 0.0001
419 LARGE INTESTINE PERFORATION 1 0.0001
420 AUTOIMMUNE HEPATITIS 1 0.0001
421 FORMICATION 1 0.0001
422 HUNGER 2 0.0001
423 DEFAECATION URGENCY 1 0.0001
424 PAPULE 1 0.0001
425 FEELING ABNORMAL 34 0.0001
426 DUODENAL ULCER 1 0.0001
427 OFF LABEL USE 124 0.0001
428 PRODUCT SUPPLY ISSUE 1 0.0001
429 HYPERSOMNIA 4 0.0001
430 NAUSEA 110 0.0001
431 FAECES SOFT 1 0.0001
432 RASH PUSTULAR 1 0.0001
433 PANIC ATTACK 5 0.0001
434 MAJOR DEPRESSION 1 0.0001
435 BLINDNESS TRANSIENT 1 0.0001
436 ARTHROPOD BITE 1 0.0001
437 FEELING DRUNK 1 0.0001
438 DIZZINESS 67 0.0001
439 SUNBURN 1 0.0001
440 DIARRHOEA 86 0.0001
441 HYPOAESTHESIA ORAL 2 0.0001
442 PAROSMIA 1 0.0001
443 LACRIMATION INCREASED 4 0.0001
444 PRODUCT AVAILABILITY ISSUE 3 0.0001
445 TROPONIN INCREASED 1 0.0001
446 TINNITUS 6 0.0001
447 DISSOCIATION 1 0.0001
448 MUSCLE TWITCHING 3 0.0001
449 PERICARDIAL EFFUSION 3 0.0001
450 HAEMOLYSIS 1 0.0001
451 CONCUSSION 1 0.0001
452 MULTIPLE ALLERGIES 1 0.0001
453 AFFECTIVE DISORDER 1 0.0001
454 RENAL CYST 1 0.0001
455 TRICUSPID VALVE INCOMPETENCE 1 0.0001
456 ABDOMINAL DISCOMFORT 21 0.0001
457 BLOOD PRESSURE FLUCTUATION 3 0.0001
458 MYASTHENIA GRAVIS 1 0.0001
459 MUSCLE DISORDER 1 0.0001
460 NEURALGIA 3 0.0001
461 BACK DISORDER 2 0.0001
462 DRUG LEVEL INCREASED 2 0.0001
463 PARAESTHESIA 19 0.0001
464 COAGULOPATHY 2 0.0001
465 GAIT INABILITY 4 0.0001
466 INFUSION SITE ERYTHEMA 1 0.0001
467 SCAR 2 0.0001
468 PRODUCT CONTAINER ISSUE 1 0.0001
469 HYPERHIDROSIS 15 0.0001
470 SKIN HYPERPIGMENTATION 1 0.0001
471 CARDIAC OPERATION 1 0.0001
472 NEUROPATHY PERIPHERAL 11 0.0001
473 DIPLOPIA 3 0.0001
474 HYSTERECTOMY 1 0.0001
475 VAGINAL HAEMORRHAGE 5 0.0001
476 ORTHOSTATIC HYPOTENSION 2 0.0001
477 URINE OUTPUT DECREASED 1 0.0001
478 DEPRESSED MOOD 6 0.0001
479 COLD SWEAT 2 0.0001
480 PRODUCT COMMUNICATION ISSUE 1 0.0001
481 PURPURA 1 0.0001
482 DRY MOUTH 9 0.0001
483 PELVIC PAIN 2 0.0001
484 MOOD ALTERED 3 0.0001
485 RESTLESS LEGS SYNDROME 2 0.0001
486 SYNCOPE 11 0.0001
487 EXOSTOSIS 1 0.0001
488 PRURITUS 42 0.0001
489 BRAIN NEOPLASM 1 0.0001
490 UROSEPSIS 1 0.0001
491 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
492 FATIGUE 84 0.0001
493 SWELLING FACE 7 0.0001
494 THINKING ABNORMAL 2 0.0001
495 RENAL IMPAIRMENT 9 0.0001
496 EYE PAIN 6 0.0001
497 ABDOMINAL DISTENSION 11 0.0001
498 PRODUCT PACKAGING ISSUE 1 0.0001
499 RECALLED PRODUCT ADMINISTERED 1 0.0001
500 EYE INFLAMMATION 1 0.0001
501 CHILLS 12 0.0001
502 VITREOUS FLOATERS 1 0.0001
503 BLOOD PRESSURE ABNORMAL 2 0.0001
504 OVARIAN CYST 1 0.0001
505 HYPOTHERMIA 1 0.0001
506 DRY THROAT 1 0.0001
507 DRUG LEVEL DECREASED 1 0.0001
508 SUBARACHNOID HAEMORRHAGE 1 0.0001
509 SLUGGISHNESS 1 0.0001
510 BODY TEMPERATURE INCREASED 2 0.0001
511 FEELING HOT 6 0.0001
512 EUPHORIC MOOD 1 0.0001
513 EAR DISCOMFORT 1 0.0001
514 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
515 HELICOBACTER INFECTION 1 0.0001
516 LIMB DISCOMFORT 3 0.0001
517 TEMPERATURE INTOLERANCE 1 0.0001
518 HYPERBILIRUBINAEMIA 1 0.0001
519 TENDERNESS 1 0.0001
520 POLLAKIURIA 4 0.0001
521 NERVOUSNESS 5 0.0001
522 ANXIETY 27 0.0001
523 VISION BLURRED 13 0.0001
524 SUDDEN DEATH 1 0.0001
525 RENAL PAIN 1 0.0001
526 MOOD SWINGS 3 0.0001
527 RETCHING 2 0.0001
528 JOINT INJURY 2 0.0001
529 DEPRESSION 21 0.0001
530 BIPOLAR DISORDER 1 0.0001
531 OESOPHAGITIS 1 0.0001
532 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
533 ARTHRALGIA 38 0.0001
534 ASPIRATION 1 0.0001
535 BLOOD GLUCOSE FLUCTUATION 1 0.0001
536 GASTROINTESTINAL PAIN 1 0.0001
537 TOOTH FRACTURE 1 0.0001
538 BLOOD PRESSURE DECREASED 6 0.0001
539 VIRAL INFECTION 3 0.0001
540 URTICARIA 15 0.0001
541 GLOSSODYNIA 2 0.0001
542 TYPE 2 DIABETES MELLITUS 3 0.0001
543 PANCREATITIS ACUTE 2 0.0001
544 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
545 ANGER 3 0.0001
546 REBOUND EFFECT 1 0.0001
547 CHEST DISCOMFORT 9 0.0001
548 DERMATITIS CONTACT 1 0.0001
549 SCAB 1 0.0001
550 INTERNAL HAEMORRHAGE 1 0.0001
551 ILLNESS 9 0.0001
552 HEART RATE DECREASED 3 0.0001
553 SPINAL PAIN 1 0.0001
554 MYOCLONUS 1 0.0001
555 HYPERLIPIDAEMIA 1 0.0001
556 POLYNEUROPATHY 1 0.0001
557 HEPATIC CANCER 2 0.0001
558 DRUG INTOLERANCE 8 0.0001
559 DYSPEPSIA 8 0.0001
560 SPINAL OPERATION 1 0.0001
561 TENDON RUPTURE 1 0.0001
562 ABNORMAL WEIGHT GAIN 1 0.0001
563 GENERALISED OEDEMA 1 0.0001
564 EYE SWELLING 3 0.0001
565 WEIGHT INCREASED 18 0.0001
566 DRY EYE 4 0.0001
567 INJECTION SITE DISCOLOURATION 1 0.0001
568 POISONING 1 0.0001
569 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
570 COLITIS 3 0.0001
571 ABDOMINAL PAIN LOWER 2 0.0001
572 CARDIOVASCULAR DISORDER 2 0.0001
573 TREMOR 13 0.0001
574 HEPATITIS 2 0.0001
575 GASTROINTESTINAL DISORDER 7 0.0001
576 SINUSITIS 8 0.0001
577 LOSS OF CONSCIOUSNESS 10 0.0001
578 CONSTIPATION 17 0.0001
579 PERIPHERAL SWELLING 12 0.0001
580 ROTATOR CUFF SYNDROME 1 0.0001
581 INFUSION SITE PAIN 1 0.0001
582 RESPIRATORY TRACT INFECTION 2 0.0001
583 SUICIDAL IDEATION 7 0.0001
584 ECZEMA 4 0.0001
585 MUSCLE SPASMS 14 0.0001
586 BEDRIDDEN 1 0.0001
587 IMMUNE SYSTEM DISORDER 1 0.0001
588 ANKYLOSING SPONDYLITIS 1 0.0001
589 TOOTH INFECTION 1 0.0001
590 DISORIENTATION 3 0.0001
591 ADVERSE REACTION 1 0.0001
592 MALIGNANT MELANOMA 1 0.0001
593 QUALITY OF LIFE DECREASED 1 0.0001
594 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
595 PAIN OF SKIN 2 0.0001
596 SINUS CONGESTION 1 0.0001
597 UVEITIS 1 0.0001
598 PALLOR 2 0.0001
599 HYPOAESTHESIA 11 0.0001
600 IMPAIRED GASTRIC EMPTYING 1 0.0001
601 ACUTE HEPATIC FAILURE 1 0.0001
602 OSTEOPOROSIS 3 0.0001
603 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
604 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
605 WITHDRAWAL SYNDROME 3 0.0001
606 CARPAL TUNNEL SYNDROME 1 0.0001
607 HEART RATE INCREASED 7 0.0001
608 FLATULENCE 4 0.0001
609 HEPATOCELLULAR INJURY 1 0.0001
610 MUSCULAR WEAKNESS 8 0.0001
611 RED BLOOD CELL COUNT DECREASED 2 0.0001
612 SUBDURAL HAEMATOMA 1 0.0001
613 SKIN BURNING SENSATION 5 0.0001
614 MOBILITY DECREASED 5 0.0001
615 IMPAIRED QUALITY OF LIFE 1 0.0001
616 ANOSMIA 1 0.0001
617 MENTAL DISORDER 3 0.0001
618 APATHY 1 0.0001
619 GASTROENTERITIS 1 0.0001
620 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
621 DEHYDRATION 9 0.0001
622 THERAPY NON-RESPONDER 3 0.0001
623 RASH 29 0.0001
624 BONE LOSS 1 0.0001
625 BLOOD POTASSIUM DECREASED 2 0.0001
626 ECONOMIC PROBLEM 1 0.0001
627 OSTEOPENIA 1 0.0001
628 SKIN IRRITATION 3 0.0001
629 SKIN DISCOLOURATION 3 0.0001
630 DEVICE ADHESION ISSUE 1 0.0001
631 THYROID DISORDER 1 0.0001
632 MUSCULOSKELETAL CHEST PAIN 1 0.0001
633 ANKLE FRACTURE 1 0.0001
634 SOMNOLENCE 13 0.0001
635 VISUAL IMPAIRMENT 8 0.0001
636 BLOOD CHOLESTEROL INCREASED 3 0.0001
637 EJECTION FRACTION DECREASED 1 0.0001
638 SWELLING 6 0.0001
639 MENINGIOMA 1 0.0001
640 PRODUCT USE COMPLAINT 1 0.0001
641 OCULAR HYPERAEMIA 3 0.0001
642 PULMONARY EMBOLISM 6 0.0001
643 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
644 HALLUCINATION, AUDITORY 1 0.0001
645 PRODUCTIVE COUGH 3 0.0001
646 OBESITY 1 0.0001
647 SENSORY DISTURBANCE 1 0.0001
648 MOVEMENT DISORDER 2 0.0001
649 CONFUSIONAL STATE 10 0.0001
650 MANIA 1 0.0001
651 EXPIRED PRODUCT ADMINISTERED 2 0.0001
652 URINARY RETENTION 2 0.0001
653 BLOOD UREA INCREASED 1 0.0001
654 CHEST PAIN 11 0.0001
655 FACE OEDEMA 1 0.0001
656 FLUID RETENTION 3 0.0001
657 MYALGIA 10 0.0001
658 JOINT SWELLING 7 0.0001
659 RASH MACULAR 2 0.0001
660 DEVICE USE ISSUE 1 0.0001
661 MALAISE 25 0.0001
662 METASTASES TO LIVER 1 0.0001
663 HYPERTENSION 12 0.0001
664 DECREASED APPETITE 13 0.0001
665 THIRST 1 0.0001
666 ASTHENIA 21 0.0001
667 GASTROENTERITIS VIRAL 1 0.0001
668 RASH PRURITIC 3 0.0001
669 VOMITING 26 0.0001
670 TOOTHACHE 1 0.0001
671 END STAGE RENAL DISEASE 1 0.0001
672 UNDERDOSE 4 0.0001
673 ACCIDENTAL OVERDOSE 2 0.0001
674 RESTLESSNESS 2 0.0001
675 PAIN IN EXTREMITY 16 0.0001
676 INJECTION SITE MASS 2 0.0001
677 INFLUENZA 6 0.0001
678 NECK PAIN 3 0.0001
679 EPISTAXIS 4 0.0001
680 BLISTER 3 0.0001
681 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
682 PHOTOPHOBIA 1 0.0001
683 URINARY TRACT INFECTION 9 0.0001
684 BLOOD URINE PRESENT 1 0.0001
685 CHRONIC KIDNEY DISEASE 4 0.0001
686 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
687 EYE IRRITATION 3 0.0001
688 SEROTONIN SYNDROME 1 0.0001
689 SEIZURE 6 0.0001
690 PRESCRIBED OVERDOSE 1 0.0001
691 DYSTONIA 1 0.0001
692 EAR PAIN 1 0.0001
693 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
694 ORAL HERPES 1 0.0001
695 BONE PAIN 3 0.0001
696 SURGERY 3 0.0001
697 KIDNEY INFECTION 1 0.0001
698 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
699 SINUS DISORDER 1 0.0001
700 UPPER LIMB FRACTURE 1 0.0001
701 PRESCRIBED UNDERDOSE 1 0.0001
702 THROMBOSIS 4 0.0000
703 PRODUCT PHYSICAL ISSUE 1 0.0000
704 PRODUCT ADMINISTRATION ERROR 1 0.0000
705 THERAPEUTIC RESPONSE DECREASED 3 0.0000
706 EXTRA DOSE ADMINISTERED 2 0.0000
707 DYSKINESIA 2 0.0000
708 DISCOMFORT 3 0.0000
709 BLINDNESS 2 0.0000
710 PRODUCT PREPARATION ERROR 1 0.0000
711 ERYTHEMA 10 0.0000
712 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
713 ROAD TRAFFIC ACCIDENT 2 0.0000
714 DERMATITIS 1 0.0000
715 SKIN EXFOLIATION 4 0.0000
716 HALLUCINATION, VISUAL 1 0.0000
717 OSTEOARTHRITIS 2 0.0000
718 EATING DISORDER 1 0.0000
719 IMPAIRED WORK ABILITY 1 0.0000
720 WEIGHT DECREASED 13 0.0000
721 SKIN CANCER 1 0.0000
722 AMNESIA 3 0.0000
723 PRODUCT DISPENSING ERROR 1 0.0000
724 ALOPECIA 9 0.0000
725 MUSCULOSKELETAL STIFFNESS 4 0.0000
726 ANGIOEDEMA 2 0.0000
727 ORAL PAIN 1 0.0000
728 ASTHMA 5 0.0000
729 PAIN 27 0.0000
730 MEMORY IMPAIRMENT 6 0.0000
731 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
732 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
733 HYPERSENSITIVITY 8 0.0000
734 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
735 BURNING SENSATION 3 0.0000
736 DYSPHAGIA 4 0.0000
737 PRODUCT PRESCRIBING ERROR 1 0.0000
738 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
739 CONTUSION 4 0.0000
740 MENTAL IMPAIRMENT 1 0.0000
741 ATRIAL FIBRILLATION 4 0.0000
742 AGITATION 3 0.0000
743 COVID-19 7 0.0000
744 HAEMATEMESIS 1 0.0000
745 FLUSHING 4 0.0000
746 HYPOPHAGIA 1 0.0000
747 DYSPNOEA 22 0.0000
748 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
749 SKIN ULCER 1 0.0000
750 EXPOSURE VIA SKIN CONTACT 1 0.0000
751 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
752 DEAFNESS 1 0.0000
753 SEDATION 1 0.0000
754 ARTHRITIS 3 0.0000
755 JOINT STIFFNESS 1 0.0000
756 NASOPHARYNGITIS 7 0.0000
757 DERMATITIS ATOPIC 2 0.0000
758 PRODUCT DOSE OMISSION ISSUE 11 0.0000
759 PRODUCT USE ISSUE 7 0.0000
760 FEAR 1 0.0000
761 DISTURBANCE IN ATTENTION 2 0.0000
762 THROAT TIGHTNESS 1 0.0000
763 LIMB INJURY 1 0.0000
764 GAIT DISTURBANCE 7 0.0000
765 RESPIRATORY ARREST 1 0.0000
766 PROCEDURAL PAIN 1 0.0000
767 OXYGEN SATURATION DECREASED 2 0.0000
768 CEREBROVASCULAR ACCIDENT 6 0.0000
769 INTENTIONAL DOSE OMISSION 1 0.0000
770 ANGINA PECTORIS 1 0.0000
771 LETHARGY 2 0.0000
772 BALANCE DISORDER 3 0.0000
773 DYSPHONIA 2 0.0000
774 LABORATORY TEST ABNORMAL 1 0.0000
775 TACHYCARDIA 3 0.0000
776 URINARY INCONTINENCE 1 0.0000
777 STOMATITIS 2 0.0000
778 ILL-DEFINED DISORDER 2 0.0000
779 PLEURAL EFFUSION 2 0.0000
780 EPILEPSY 1 0.0000
781 EMOTIONAL DISORDER 1 0.0000
782 BREAST CANCER 3 0.0000
783 NERVOUS SYSTEM DISORDER 1 0.0000
784 PYREXIA 11 0.0000
785 HEAD INJURY 1 0.0000
786 CYSTITIS 1 0.0000
787 HYPOTHYROIDISM 1 0.0000
788 INTENTIONAL OVERDOSE 2 0.0000
789 RHINORRHOEA 2 0.0000
790 EYE DISORDER 1 0.0000
791 STAPHYLOCOCCAL INFECTION 1 0.0000
792 LIP SWELLING 1 0.0000
793 DRY SKIN 4 0.0000
794 INJECTION SITE PRURITUS 2 0.0000
795 MYOCARDIAL INFARCTION 5 0.0000
796 HYPOXIA 1 0.0000
797 LYMPHADENOPATHY 1 0.0000
798 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
799 PRODUCT ADHESION ISSUE 1 0.0000
800 OVERDOSE 6 0.0000
801 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
802 C-REACTIVE PROTEIN INCREASED 1 0.0000
803 DYSURIA 1 0.0000
804 FALL 9 0.0000
805 BRONCHITIS 2 0.0000
806 DYSPNOEA EXERTIONAL 1 0.0000
807 ACNE 2 0.0000
808 DIABETES MELLITUS 2 0.0000
809 DRUG DOSE OMISSION BY DEVICE 2 0.0000
810 INJECTION SITE BRUISING 2 0.0000
811 COUGH 7 0.0000
812 EMOTIONAL DISTRESS 3 0.0000
813 NEUTROPHIL COUNT DECREASED 1 0.0000
814 LUNG NEOPLASM MALIGNANT 1 0.0000
815 INFLUENZA LIKE ILLNESS 2 0.0000
816 TREATMENT FAILURE 2 0.0000
817 RHABDOMYOLYSIS 1 0.0000
818 COLITIS ULCERATIVE 1 0.0000
819 ADVERSE DRUG REACTION 2 0.0000
820 PRODUCT QUALITY ISSUE 3 0.0000
821 NEPHROLITHIASIS 1 0.0000
822 HYPOKALAEMIA 1 0.0000
823 RENAL DISORDER 1 0.0000
824 COGNITIVE DISORDER 1 0.0000
825 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
826 BLOOD GLUCOSE DECREASED 1 0.0000
827 INTERSTITIAL LUNG DISEASE 1 0.0000
828 HYPOGLYCAEMIA 1 0.0000
829 LEUKOPENIA 1 0.0000
830 INFLAMMATION 1 0.0000
831 OEDEMA 1 0.0000
832 SEPSIS 2 0.0000
833 THROMBOCYTOPENIA 2 0.0000
834 HYPONATRAEMIA 1 0.0000
835 INCORRECT DOSE ADMINISTERED 4 0.0000
836 INJECTION SITE ERYTHEMA 2 0.0000
837 ANAEMIA 3 0.0000
838 PNEUMONIA 5 0.0000
839 DEEP VEIN THROMBOSIS 1 0.0000
840 DEVICE DIFFICULT TO USE 1 0.0000
841 INFUSION RELATED REACTION 1 0.0000
842 FEBRILE NEUTROPENIA 1 0.0000
843 RENAL FAILURE 2 0.0000
844 NEOPLASM MALIGNANT 1 0.0000
845 DEVICE MALFUNCTION 1 0.0000
846 INJURY 1 0.0000
847 THERAPY INTERRUPTED 1 0.0000
848 DYSGEUSIA 1 0.0000
849 HALLUCINATION 1 0.0000
850 ACUTE KIDNEY INJURY 2 0.0000
851 INJECTION SITE SWELLING 1 0.0000
852 INJECTION SITE PAIN 4 0.0000
853 INJECTION SITE HAEMORRHAGE 1 0.0000
854 CARDIAC FAILURE 1 0.0000
855 PROSTATE CANCER 1 0.0000
856 PRODUCT STORAGE ERROR 1 0.0000
857 DEVICE ISSUE 1 0.0000
858 NO ADVERSE EVENT 2 0.0000
859 OROPHARYNGEAL PAIN 1 0.0000
860 CARDIAC DISORDER 1 0.0000
861 BLOOD GLUCOSE INCREASED 2 0.0000
862 HYPOTENSION 2 0.0000
863 HAEMOGLOBIN DECREASED 1 0.0000
864 HAEMORRHAGE 1 0.0000
865 PLATELET COUNT DECREASED 1 0.0000
866 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
867 RHEUMATOID ARTHRITIS 1 0.0000
868 DISEASE PROGRESSION 1 0.0000
869 OEDEMA PERIPHERAL 1 0.0000
870 PSORIASIS 1 0.0000
871 INFECTION 1 0.0000
872 DRUG DEPENDENCE 1 0.0000
873 DEATH 3 0.0000